NCT00755352 - A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Pravastatin for at Least 4 Weeks. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

June 30, 2003

Study Completion Date

April 30, 2005

Conditions

Hypercholesterolemia

Interventions

DRUG

pravastatin tablets and Welchol tablets

pravastatin tablets, 1 tablet/day for 6 weeks; Welchol Tablets, 6 tablets/day for 6 weeks

DRUG

pravastatin tablets and Welchol placebo tablets

pravastatin tablets, 1 tablet/day; Welchol placebo tablets, 6 tablets/day

Trial Locations (15)

Los Angeles

Castle Rock

Jacksonville

Pembroke Pines

St. Petersburg

Chicago

Indianapolis

Louisville

Rochester

Cincinnati

Cleveland

Bartlett

Norfolk

Richmond

Seattle